$225.00
BPC-157 and TB-500 are peptides that have been studied for their potential roles in tissue repair, inflammation modulation, and recovery. BPC-157 is known for promoting healing and regeneration, while TB-500 (Thymosin Beta-4) has been explored for its impact on cellular migration and tissue repair. When combined, these peptides are of interest in research for their synergistic effects on musculoskeletal and soft tissue recovery.
BPC-157 / TB-500 Capsules 1mg is a high-purity, gastric-stable oral research formulation combining an angiogenic gastric protection peptide with an actin-sequestering cell motility protein. Engineered to study maximum regenerative synergy, this convenient oral delivery format serves as a core investigative tool for tracking systemic soft tissue healing, tendon/ligament fibroblast repair, and gastrointestinal mucosal barrier integrity in laboratory models.
Supplied as stable, precisely dosed 1mg research capsules. Restricted strictly to laboratory and in vitro evaluation.
Eterna Peptides presents premium-grade BPC-157 / TB-500 Capsules (1mg), an advanced oral research formulation combining two of the most heavily investigated regenerative peptides in a precise, stable delivery format. Each capsule provides a synergistically balanced profile engineered to study systemic tissue recovery, cellular migration, and mucosal barrier stabilization.
Mechanism of Action
This dual-peptide capsule formulation combines distinct, non-overlapping physiological pathways to explore comprehensive structural and systemic repair:
* **BPC-157 (Body Protection Compound-157):** A stable synthetic pentadecapeptide modeled after a natural protective protein found in gastric juice. It stands out in oral research for its high structural stability against gastric acid degradation. BPC-157 upregulates growth hormone receptors, promotes fibroblast migration, and activates angiogenic (new blood vessel) pathways via VEGF expression.
* **TB-500 (Thymosin Beta-4 Fragment):** A synthetic fragment of the naturally occurring peptide Thymosin Beta-4, heavily studied for its actin-sequestering properties. It governs cell motility, accelerates wound-healing kinetics, and assists in the structural alignment of newly synthesized proteins at localized injury sites.
Research Applications
In preclinical and in vitro laboratory models, BPC-157 / TB-500 oral capsules are extensively utilized to investigate:
* Accelerated repair pathways for connective soft tissues, including tendons, ligaments, and skeletal muscles.
* Gastrointestinal tract integrity, mucosal lining repair, and inflammatory bowel disease models.
* Systemic anti-inflammatory cellular signaling and microvascular perfusion restoration.
* The comparative bioavailability and experimental stability of oral peptide delivery systems vs. lyophilized solutions.
Our BPC-157 / TB-500 capsules are manufactured under strict laboratory quality control conditions to ensure absolute dosage accuracy, structural peptide integrity, and reliable batch-to-batch reproducibility.
—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*
